When Healthy Cells Merge: Fusion Events Trigger Genome Chaos That May Ignite Cancer

Cell fusion is one of biology’s most fundamental processes, quietly shaping our bodies long before we are born. It builds muscle fibers, constructs the placenta, forms bone-resorbing osteoclasts and drives embryonic development. In healthy tissue, fusion is strictly choreographed: nuclei within multinucleated syncytia remain spatially separated and mitotically inactive, allowing tissue growth and protein synthesis without compromising genomic integrity. But what happens when this precision breaks down? A new study published in Cancer Cell International by Julian Weiler, Grigorios Raphael Topsis and Thomas Dittmar of Witten/Herdecke University provides a striking answer. When non-transformed breast epithelial cells fuse spontaneously, the resulting hybrid cells descend into a state of catastrophic genomic instability that mirrors the earliest, most chaotic moments of cancer evolution.

The team’s central question was deceptively simple: can the merger of two genetically identical, non-malignant cells set in motion the kind of genome-wide upheaval that is normally associated with tumor initiation? The answer, documented across karyotypic, morphological, transcriptomic and phenotypic analyses, is a resounding yes. The researchers labeled the nuclei of M13SV1 human breast epithelial cells with two different fluorescent histone tags, H2B-GFP and H2B-mCherry, and co-cultured the two populations. Any cell that spontaneously fused would carry both colors in its nucleus, allowing the team to pick out and propagate individual hybrid clones derived from nothing more than unscheduled fusion between healthy cells.

Flow cytometry revealed that these hybrids began life near-tetraploid, carrying roughly double the normal complement of chromosomes, and were already saturated with DNA damage. Using the γ-H2AX marker, which flags double-strand breaks, the researchers found that up to ten percent of cells in the hybrid populations displayed damage foci, concentrated overwhelmingly in the S and M phases of the cell cycle. This is a crucial detail: it suggests that most of the damage arises during DNA replication and is carried straight into mitosis without repair. When the team visualized dividing hybrid cells under a confocal laser-scanning microscope, they saw a gallery of mitotic horrors, including multipolar spindles, lagging chromosomes and extrachromosomal DNA, with γ-H2AX foci present in every dividing cell examined.

Whole-genome doubling is far from a rare curiosity in human cancer. Pan-cancer genome studies indicate that approximately 30 to 37 percent of cancer cells within solid tumors carry a tetraploid karyotype resulting from a whole-genome doubling event, which can arise through endocycling, mitotic slippage, endomitosis, cytokinesis failure or cell fusion. Cells with more than two chromosome sets are predisposed to chromosomal instability because extra centrosomes and oversized genomes create fertile ground for segregation errors. Merotelic kinetochore attachments, in which microtubules from opposing spindle poles compete for the same chromosome, produce lagging chromosomes that become trapped in the cleavage furrow and eventually form their own micronuclei. Because micronuclei possess defective nuclear laminae, the DNA inside them suffers strand breaks and large-scale rearrangements, a process that can culminate in chromothripsis, the shattering and random reassembly of entire chromosomes.

Perhaps the most provocative finding of the new study concerns what happened when the hybrid clones were passaged over the long term. Between early passages (4 to 6) and late passages (20 to 22), all three hybrid clones underwent a ploidy reduction, shifting from near-tetraploid to near-triploid or, in one case, a mixed near-triploid and near-diploid state. Crucially, this reduction in genome size was not accompanied by any reduction in DNA damage. The burden of lesions remained constant or even increased, and the heaviest damage continued to accumulate during replication and mitosis. The researchers interpret this as evidence of ploidy-dependent replication stress: a doubled genome demands nucleotides and replication factors that the cell cannot supply in proportion, causing replication forks to stall and collapse, and generating the double-strand breaks that fuel ongoing chromosomal instability.

Single-cell fate tracking painted an equally dramatic picture. Compared with diploid parental cells, in which roughly one fifth of divisions went awry and most aberrant progeny promptly died, the hybrid clones exhibited aberrant mitotic outcomes in 40 to 60 percent of tracked divisions. These included multipolar division, endoreplication, failed cytokinesis and even refusion, in which daughter cells merged back together after mitosis. The hybrids also survived these errors far more successfully than their diploid parents, a resilience the authors attribute to their extra chromosome copies, which buffer against the lethal loss of essential genes. Over time, the hybrid populations even regained proliferative capacity, with late-passage clones outgrowing the parental cells, suggesting that an ongoing post-hybrid selection process was actively favoring faster-growing subclones.

Morphometric analysis added another layer of intrigue. Early-passage hybrids were enlarged by only 15 to 40 percent in cell area despite carrying roughly double the DNA, and their nuclei were 20 to 60 percent larger than those of diploid controls. As passages accumulated and ploidy fell, both cell and nuclear size shrank in a hybrid-clone-dependent manner, with one clone’s cell area returning almost exactly to the diploid baseline even as its nucleus remained enlarged. The team also documented a striking degree of nuclear deformation, with multi-lobulation, invagination and nuclear blebbing persisting across all passages. A Pearson correlation analysis revealed that the degree of nuclear deformation was positively correlated with the amount of DNA damage, particularly during the S and M phases, supporting the idea that a distorted nuclear architecture and genomic instability reinforce one another in a vicious cycle.

Transcriptomic profiling by RNA sequencing exposed the malignant potential simmering beneath this chromosomal chaos. All three hybrid clones shared 427 differentially expressed genes relative to the parental cells, and enrichment analysis showed that genes linked to epithelial-mesenchymal transition, or EMT, hypoxia, p53 signaling and xenobiotic metabolism were consistently upregulated. Western blots confirmed that the hybrids had lost the epithelial marker E-cadherin in two clones and gained the mesenchymal markers N-cadherin and vimentin, hallmarks of a phenotypic switch toward motility and invasiveness. Functional assays backed this up: hybrid clones formed more colonies and larger mammospheres than parental cells, and two clones showed markedly enhanced migratory and invasive behavior. Notably, EMT gene expression was enriched only in late-passage hybrids, suggesting that the mesenchymal switch is a subclonal evolutionary process rather than an immediate consequence of fusion.

One chromosomal region stood out in the transcriptional mapping. The p36 locus on chromosome 1 was significantly downregulated in every hybrid clone, and within the 1p36.33 to 1p36.31 segment, the tumor suppressor gene AJAP1 was the most heavily silenced, with log2 fold changes ranging from minus six to minus ten. This is a finding with clear clinical resonance. Deletion of 1p36 is a common event across many cancer types, and analysis of the TCGA pan-cancer dataset showed that copy number loss of this region is associated with worse overall survival. AJAP1 expression was lower in tumor tissue than in healthy tissue, lowest of all in metastatic lesions, and reduced AJAP1 levels correlated with higher patient mortality. Because AJAP1 is known to inhibit EMT, its near-complete loss in the hybrids fits neatly with their mesenchymal, migratory phenotype.

Taken together, the study frames atypical cell fusion as a potential catastrophic event in carcinogenesis, comparable in its genomic consequences to chromothripsis or chromoplexy, which pan-cancer analyses have detected in more than a fifth of tumors. A single fusion event instantly doubles the genome, disrupts the cytoplasm, duplicates centrosomes and forces the hybrid cell through a first mitosis in which parental genomes collide, unleashing genome chaos at a macroevolutionary pace. The surviving hybrids, buffered by their extra chromosomes and shaped by relentless selection, drift toward smaller, faster-growing, more motile subclones with premalignant transcriptional signatures. While the researchers caution that further work, including limited-dilution and transplantation experiments, is needed to confirm true tumor-initiating capacity, the message is clear: the road to cancer may sometimes begin not with a mutation in a single gene, but with two healthy cells making the fateful decision to become one.

Subject of Research: Spontaneous fusion of non-transformed breast epithelial cells inducing genome chaos, chromosomal instability and premalignant hybrid phenotypes

Article Title: Atypical fusion among non-malignant cells: Unveiling the link between post-fusion-induced genome chaos and cancer initiation

Article References: Atypical fusion among non-malignant cells: Unveiling the link between post-fusion-induced genome chaos and cancer initiation. (n.d.). https://doi.org/10.1186/s12935-026-04466-1

Image Credits: AI Generated

DOI: 10.1186/s12935-026-04466-1

Keywords: cell fusion, genome chaos, chromosomal instability, polyploidy, whole-genome doubling, breast epithelial cells, EMT, micronuclei, AJAP1, 1p36 deletion, cancer initiation, hybrid cells